Vaccine innovation done differently
- PMID: 21124708
- PMCID: PMC2995195
- DOI: 10.2471/BLT.10.082826
Vaccine innovation done differently
Similar articles
-
The problems and promise of vaccine markets in developing countries.Health Aff (Millwood). 2005 May-Jun;24(3):690-3. doi: 10.1377/hlthaff.24.3.690. Health Aff (Millwood). 2005. PMID: 15886160
-
Vaccine advance-purchase agreements for low-income countries: practical issues.Health Aff (Millwood). 2005 May-Jun;24(3):653-65. doi: 10.1377/hlthaff.24.3.653. Health Aff (Millwood). 2005. PMID: 15886157
-
Global vaccine supply. The increasing role of manufacturers from middle income countries.Vaccine. 2014 Sep 15;32(41):5259-65. doi: 10.1016/j.vaccine.2014.07.069. Epub 2014 Aug 8. Vaccine. 2014. PMID: 25110294
-
Global perspectives on vaccine financing.Expert Rev Vaccines. 2004 Oct;3(5):557-62. doi: 10.1586/14760584.3.5.557. Expert Rev Vaccines. 2004. PMID: 15485335 Review.
-
Vaccine shortages: history, impact, and prospects for the future.Annu Rev Public Health. 2006;27:235-59. doi: 10.1146/annurev.publhealth.27.021405.102248. Annu Rev Public Health. 2006. PMID: 16533116 Review.
References
-
- AIDS vaccines for the world: preparing now to assure access. New York: International AIDS Vaccine Initiative; 2000.
-
- Institute of Medicine. Vaccine supply and innovation Washington: National Academy Press; 1985.
-
- Institute of Medicine. Vaccines for the 21st century Washington: National Academy Press; 2000.
-
- Clemens JD, Jodar L. Translational research to assist policy decisions about introducing new vaccines in developing countries. J Health Popul Nutr. 2004;22:223–31. - PubMed
-
- Meningitis vaccine receives crucial approval: Prequalification clears the way for phased introduction of MenAfriVac (media release). Seattle: PATH; 2010 Available from: http://www.path.org/news/an100623-menafrivac.php [accessed 8 November 2010].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical